Showing results (201-210 of 366) with videos related to

Sort By:
Pageof 37
Addictive Behaviors|April 15, 2021
Daily meaningfulness among patients with opioid use disorder: Examining the role of social experiences during residential treatment and links with post-treatment relapseKyler S Knapp, Timothy R Brick, Scott C Bunce, et al.
Journal of Clinical Microbiology|September 1, 1991
Molecular characterization of Haemophilus ducreyi by ribosomal DNA fingerprintingS K Sarafian, T C Woods, J S Knapp, et al.
Journal of Substance Use and Addiction Treatment|March 7, 2023
Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance useH Harrington Cleveland, Kyler S Knapp, Michael J Cleveland, et al.
Sexually Transmitted Diseases|July 1, 1988
Penicillinase-producing Neisseria gonorrhoeae in Dade County, Florida: phenotypic characterization of isolates from 1983, 1984, and 1986J M Zenilman, W L Whittington, D Frazier, et al.
Infection and Immunity|August 1, 1990
A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterationsC K Lee, A L Roberts, T M Finn, et al.
The Journal of Infectious Diseases|August 1, 1978
Phenotypic and epidemiologic correlates of auxotype in Neisseria gonorrhoeaeJ S Knapp, C Thornsberry, G A Schoolnik, et al.
Sexually Transmitted Diseases|June 14, 2001
Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999D L Trees, A L Sandul, S W Neal, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1993
In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroidJ S Knapp, A F Back, A F Babst, et al.
Annals of the Rheumatic Diseases|October 1, 1982
Time of day of prednisolone administration in rheumatoid arthritisI C Kowanko, R Pownall, M S Knapp, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of dayI C Kowanko, R Pownall, M S Knapp, et al.
Pageof 37